JBC Origene Your Gene Company

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M206115200 on July 10, 2002

J. Biol. Chem., Vol. 277, Issue 38, 35202-35209, September 20, 2002
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/38/35202    most recent
M206115200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Segall, L.
Right arrow Articles by Blostein, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Segall, L.
Right arrow Articles by Blostein, R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

New Insights into the Role of the N Terminus in Conformational Transitions of the Na,K-ATPase*

Laura SegallDagger , Lois K. Lane§, and Rhoda BlosteinDagger

From the Dagger  Department of Biochemistry, McGill University, Quebec H3G 1A4, Canada and the § Department of Pharmacology, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267-0575

Received for publication, June 19, 2002, and in revised form, July 9, 2002

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The deletion of 32 residues from the N terminus of the alpha 1 catalytic subunit of the rat Na,K-ATPase (mutant alpha 1M32) shifts the E1/E2 conformational equilibrium toward E1, and the combination of this deletion with mutation E233K in the M2-M3 loop acts synergistically to shift the conformation further toward E1 (Boxenbaum, N., Daly, S. E., Javaid, Z. Z., Lane, L. K., and Blostein, R. (1998) J. Biol. Chem. 273, 23086-23092). To delimit the region of the cytoplasmic N terminus involved in these interactions, the consequences of a series of N-terminal deletions of alpha 1 beyond Delta 32 were evaluated. Criteria to assess shifts in conformational equilibrium were based on effects of perturbation of the entire catalytic cycle ((i) sensitivity to vanadate inhibition, (ii) K+ sensitivity of Na-ATPase measured at micromolar ATP, (iii) changes in K'ATP, and (iv) catalytic turnover), as well as estimates of the rates of the conformational transitions of phospho- and dephosphoenzyme (E1P right-arrow E2P and E2(K+) right-arrow E1 + K+). The results show that, compared with alpha 1M32, the deletion of up to 40 residues (alpha 1M40) further shifts the poise toward E1. Remarkably, further deletions (mutants alpha 1M46, alpha 1M49, and alpha 1M56) reverse the effect, such that these mutants increasingly resemble the wild type alpha 1. These results suggest novel intramolecular interactions involving domains within the N terminus that impact the manner in which the N terminus/M2-M3 loop regulatory domain interacts with the M4-M5 catalytic loop to effect E1 left-right-arrow E2 transitions.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The Na,K-ATPase or sodium pump is a ubiquitous integral membrane protein that catalyzes the glycoside sensitive, ATP-coupled exchange of three intracellular Na+ for two extracellular K+ ions across the plasma membrane of all animal cells. The sodium pump is essential to the maintenance of the electrochemical gradients of Na+ and K+ across the cell membrane, providing the driving force for the transport of nutrients into the cell and maintaining the cellular resting membrane potential. It comprises two essential subunits: a large catalytic alpha  subunit (~100 kDa), containing the ligand binding and phosphorylation sites and a smaller, highly glycosylated beta  subunit (~35-55 kDa), which acts as a chaperone for alpha  (for review see Refs. 1 and 2). A third subunit, gamma  (~7 kDa), was found in the kidney where it functions as a regulator of the pump (see Refs. 3 and 4).

The sodium pump is a member of a family of transporters known as P-type ATPases that are directly phosphorylated and dephosphorylated on a conserved aspartate residue within their cytoplasmic domain during the course of the reaction cycle. Both the phosphorylated and dephosphorylated forms of the enzyme can exist in at least two states that undergo conformational transitions (E1P right-arrow E2P and E2 right-arrow E1) that are coupled to the ion-translocating steps. Definitive evidence for distinct E1 and E2 conformational states and a role of the N terminus in effecting E1 left-right-arrow E2 transitions was first obtained in 1975 by Jorgensen (5, 6) using tryptic cleavage of the renal enzyme in the presence of different ligands. Later confirmatory evidence was obtained using N-terminal deletion mutants expressed in cultured cells (7). This study showed that whereas deleting up to and including the lysine-rich cluster is without effect, removal of 32 residues (mutant alpha 1M32) alters the enzyme kinetics by shifting the E1/E2 conformational equilibrium toward E1 forms. Interestingly, a similar shift toward E1 is caused by Glu233 right-arrow Lys substitution in the first (M2-M3) cytoplasmic loop. Furthermore, the combined removal of the N-terminal 32 residues and replacement of Glu233 right-arrow Lys (mutant alpha 1M32E233K) results in a remarkably synergistic shift in poise toward E1 state(s) as evidenced in analyses of several characteristic properties including, for examples, extraordinary insensitivity to vanadate, high affinity for ATP (5 µM), and slow (<= 500 min-1) catalytic turnover of alpha 1M32E233K. These findings were interpreted to indicate that interactions between these two cytoplasmic regions and the M4-M5 catalytic loop are critical for conformational coupling (8).

The present study was carried out to define more precisely the role of the N terminus in conformational transitions. Accordingly, we investigated the consequences of further deletions of the N terminus of the Na,K-ATPase beyond the first 32 residues to near the beginning of the first transmembrane segment, using several criteria to assess shifts in the steady-state E1 left-right-arrow E2 poise. The results of this analysis reveal a progressively increased shift in the E1/E2 poise toward E1, followed by reversal toward the wild type alpha 1 E1/E2 distribution. Combined with secondary structure predictions of the N terminus, this behavior identifies a self-regulatory domain within the N terminus of the Na,K-ATPase that modulates conformational transitions via novel intramolecular interactions.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Determination of Helicity-- Predictions of the secondary structure of the N-terminal sequence were evaluated using the following algorithms: PREDATOR (9), Sspro (10), SOPMA (11), GOR IV (12), Deleage and Roux (13), Levitt (14), Chou and Fasman (15), COILS v2.1 (16), and PSA (17). Putative helical regions were then ascribed to those sequences for which the above algorithms concur on helicity.

Mutagenesis, Transfection, Selection, and Cell Culture-- The desired mutations were introduced into the 5' SacI230-SalI875 restriction fragment cassette of the rat alpha 1 cDNA as described previously (7). The mutant cassettes were then ligated into the rat alpha 1 cDNA in the place of the wild type SacI-SalI cassette. The full-length mutant cDNAs were released form the shuttle vector by digestion with HindIII, ligated into the expression plasmid pCDNA3.1 (Invitrogen), and orientation of the cDNA was determined by restriction analysis. HeLa cells were transfected with the pCDNA-alpha 1 mutant constructs using either the calcium phosphate method (18) or the LipofectAMINE technique (Invitrogen), and cells expressing the relatively ouabain-resistant rat alpha 1 enzymes and mutants thereof were selected as described previously (19, 20). HeLa cells expressing the mutant alpha 1 enzymes were amplified in Dulbecco's modified Eagle's medium plus 10% newborn calf serum, 100 units/mg penicillin G, 100 µg/ml streptomycin, and 1 µM ouabain as described previously (7). The above medium was initially supplemented with an additional 15 mM KCl (20 mM total; see Ref. 21), which was removed after several passages.

Membrane Preparation-- NaI-treated microsomal membranes were prepared from the mutant cells as described earlier (19, 20). Protein content was determined with a detergent-modified Lowry assay (22).

Enzyme Assays-- Na,K-ATPase activity was measured as the release of 32Pi from [gamma -32P]ATP as previously described (23). Briefly and unless indicated otherwise, the membranes were preincubated for 10 min at 37 °C with all reactants added except [gamma -32P]ATP. The reaction was initiated by the addition of [gamma -32P]ATP. Final concentrations for Na,K-ATPase activity measurements were 100 mM NaCl, 10 mM KCl, 3 mM MgSO4, 20 mM histidine (pH 7.4), 5 mM EGTA (pH 7.4), and 5 µM ouabain (SIGMA). 5 mM ouabain was used to determine baseline hydrolysis activity. As in earlier studies and unless indicated otherwise, assays of Na,K-ATPase activity were carried out using 1 mM ATP to maintain close to saturating ATP concentration and also maximize sensitivity of assays of the relatively low activity cultured cells (see Refs. 20, 24, and 25). Na-ATPase activity was measured at 1 µM ATP as described previously (7), with varying amounts of added KCl and choline chloride to maintain constant chloride (40 mM) concentration, and baseline activity was determined with 40 mM KCl. For studies of vanadate sensitivity, inorganic orthovanadate (Fisher) solutions were prepared prior to the experiment and added with the [gamma -32P]ATP solution to initiate the reaction. Na,K-ATPase activities obtained at various vanadate concentrations and expressed as percentage of that obtained in the absence of vanadate, were analyzed by fitting the data to a one-compartment model using a non-linear least-square analysis of a general logistic function, as described elsewhere (26).

Phosphoenzyme Determination-- Phosphoenzyme levels were determined as described earlier (25). Briefly, membranes (~0.01 mg/assay) were preincubated with ouabain (20 µM ouabain, 0.4 mM MgSO4, and 10 mM glycylglycine-Tris (pH 7.4)) for 10 min at 37 °C to inhibit endogenous HeLa Na,K-ATPase. The suspension was then treated with either oligomycin (20 µg/ml) for 1 min at room temperature or with vehicle alone (ethanol) for baseline measurements (see below). Phosphorylation was then carried out for 10 s at 0 °C in a final volume of 150 µl in medium comprising (final concentrations) 100 mM NaCl, 10 mM glycylglycine-Tris (pH 7.4), 5 mM EGTA, 1 mM MgSO4, and 1 µM [gamma -32P]ATP (specific activity 10,000-20,000 cpm/pmol). Baseline EP levels were determined by replacing 100 mM NaCl with 50 mM KCl and 50 mM choline chloride, and phosphorylating the enzyme in the absence of oligomycin.

Formation of the E1 from E2(K+)-- The rate of K+ deocclusion (E2(K+) right-arrow E1 + K+) was measured indirectly by determining the rate of E1 formation from E2(K+) as described elsewhere (25), with the modifications described by Therien and Blostein (27).

Rate of E1P right-arrow E2P-- Following formation of E1P in the presence of high chloride concentration (28), the rate of E1P right-arrow E2P was determined by measuring the rate of disappearance of total phosphoenzyme following rapid dilution of the salt (to allow normal relaxation of E1P right-arrow E2P) plus addition of KCl to catalyze rapid hydrolysis of E2P (28, 29). Accordingly, the enzyme was first phosphorylated in medium containing 600 mM NaCl to stabilize E1P, 1 mM MgCl2, 1 mM EGTA, and 20 mM Tris-HCl (pH 7.4) with 1 µM [gamma -32P]ATP for 30 s at 0 °C to obtain maximal phosphoenzyme. Dephosphorylation was then initiated by 6-fold dilution with a chase medium containing final concentrations of 20 mM KCl, 10 µM unlabeled ATP, 1 mM EGTA, and 20 mM Tris-HCl (pH 7.4), which simultaneously lowered the NaCl concentration to 100 mM. Samples were taken for measurement of E32P for periods of up to 30 s. Background phosphoenzyme levels were obtained by allowing the chase to continue for 60 s.

At least two different membrane preparations obtained from at least two different clones were assayed. The data presented are representative of at least three independent experiments. Each value shown is the mean ± S.D. of triplicate determinations.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

To determine more precisely the structural basis and mechanism underlying the role of the cytoplasmic N terminus of the alpha 1 catalytic subunit of the Na,K-ATPase on the steady-state E1 right-arrow E2 conformational poise, we first considered the nature of the secondary structure of this 85-residue N-terminal domain. This region is a highly charged, flexible structure with a high degree of helicity. A comparison of the results of several computational analyses (see "Experimental Procedures") reveals the presence of three putative alpha -helical domains encompassing residues 27-33, 42-50 and 61-68 (Fig. 1). To remove or disrupt these regions, wild type HeLa cells were transfected with N-terminal deletion mutants of the alpha 1 subunit of the rat Na,K-ATPase corresponding to either disruption or loss of the first putative helix (alpha 1M32 and alpha 1M40, respectively) and disruption (alpha 1M46 and alpha 1M49) or loss (alpha 1M56) of the second helix (Fig. 1). All five of the mutant constructs yielded functional enzyme capable of sustaining HeLa cell growth in 1 µM ouabain.


View larger version (11K):
[in this window]
[in a new window]
 
Fig. 1.   N terminus of the rat alpha 1 Na,K-ATPase and deletion mutants thereof. Computational analysis of the N-terminal sequence predicts three helices in the N-terminal of the alpha 1 Na,K-ATPase within, at least, residues 27-33, 42-50, and 61-68 (for details see "Experimental Procedures"). Numbering is based on the mature rat alpha 1 amino acid sequence (60).

Several criteria were used to analyze shifts in the E1/E2 distribution: some that reflect the operation of the overall catalytic cycle and others that reflect partial reactions relevant to the major E1 left-right-arrow E2 and E1P left-right-arrow E2P transitions. The former include: (i) sensitivity of Na,K-ATPase activity to inhibition by vanadate, (ii) response of Na-ATPase to varying K+ concentrations relevant to the normally rate-limiting E2(K+) right-arrow right-arrow E1 + K+, (iii) catalytic turnover, and (iv) K'ATP relevant to low affinity ATP binding to E2(K+). The latter include: (v) rate of K+ deocclusion [E2(K+) right-arrow right-arrow E2 + K+] (see (ii) above), and (vi) rate of E1P right-arrow E2P as outlined in "Experimental Procedures."

Functional Consequences of Deletion Mutants: (i) Analysis of the Overall Catalytic Cycle under Steady State Conditions-- Compared with the wild type alpha 1 enzyme, the poise in E1 left-right-arrow E2 of the alpha 1M32 deletion mutant is notably shifted toward E1 forms of the enzyme (7, 25). To gain insight into the effects of further deletions on conformational equilibrium, we investigated the effect of vanadate on Na,K-ATPase activity. Inorganic orthovanadate is a transition state analog of inorganic phosphate that binds to P-type ATPases in the E2 conformation (30). Consequently, sensitivity of an enzyme to inhibition by vanadate is a measure of the proportion of enzyme in the E2 conformation. As shown by the representative experiment in Fig. 2 and summarized in Table I, alpha 1M32 and alpha 1M40 are both less sensitive to vanadate inhibition than is alpha 1, suggesting that the E1/E2 equilibrium of these enzymes progressively shifts toward E1 as up to 40 residues are deleted from the N terminus. However, this shift is reversed to a more wild type-like sensitivity by deleting >= 46 residues (mutants alpha 1M46, alpha 1M49, and alpha 1M56).


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 2.   Vanadate sensitivity of N-terminal deletion mutants. ATP hydrolysis at varying vanadate concentrations was determined with 100 mM NaCl, 10 mM KCl, and 1 mM ATP as described under "Experimental Procedures." Data are presented as percent Na,K-ATPase (control) measured in the absence of vanadate. Results shown are from a representative experiment; shown are mean ± S.D. of triplicate determinations. Symbols are: , alpha 1 (dashed line); , alpha 1M32; diamond , alpha 1M40; X, alpha 1M46; down-triangle, alpha 1M49; triangle , alpha 1M56.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Summary of kinetic behavior of Na,K-ATPase mutants during steady-state catalysis

At micromolar ATP concentrations, sufficient to saturate only the high affinity phosphorylation site, the response of Na-ATPase to K+ is a sensitive means to characterize mutant-specific differences in the K+ deocclusion pathway of the reaction cycle (E2(K+) right-arrow right-arrow E1 + K+], which becomes rate-limiting under these conditions (7, 31). Thus, as shown previously and in Fig. 3, K+ inhibits the Na-ATPase activity of alpha 1 but stimulates that of alpha 1M32. The deletion of 40 residues, alpha 1M40, results in an even greater K+ stimulation, up to ~400%. Interestingly, further deletion, i.e. alpha 1M46, alpha 1M49, and alpha 1M56, yields alpha 1-like K+ inhibition. These results, summarized in Table I, suggest a progressive shift in the E1/E2 conformational equilibrium toward E1 upon removal of up to 40 residues from the N terminus, which is reverted by deleting >= 46 residues.


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 3.   K+ sensitivity of Na-ATPase. ATP hydrolysis was assayed in the presence of 1 µM ATP, 20 mM NaCl, and various concentrations of KCl as described under "Experimental Procedures." Data are presented as percent of Na-ATPase activity (control) measured in the absence of added KCl. Results shown are from a representative experiment. Values are the mean ± S.D. of triplicate determinations. Symbols are as in the legend to Fig. 2.

The catalytic turnover of the Na,K-ATPase is estimated as the ratio of VMAX to EPMAX, the latter measured at 0 °C in the presence of ATP, Na+, and oligomycin to trap the enzyme in the (Na+)E1P state (see "Experimental Procedures") (32). Table I shows the catalytic turnover of alpha 1 and the mutant enzymes. As previously shown, alpha 1M32 has ~50% reduction in turnover, consistent with a shift in the E1 left-right-arrow E2 poise toward E1. alpha 1M40 has a significantly lower turnover, only 20% that of alpha 1. In contrast, deletion of >= 46 residues restores the catalytic turnover to near that of alpha 1.

Differences in K+ sensitivity of Na-ATPase at low ATP con-centration (Fig. 3) suggest a change in the rate of a step in the K+ deocclusion phase of the Albers-Post reaction mechanism, which can be modeled by a branched pathway (see Scheme 1 in Ref. 33). In one branch, pathway A, ATP first binds with low affinity denoted by K'ATP(L), to the K+ occluded enzyme, followed by rapid deocclusion (ATP·E2(K+) right-arrow ATP·E1·K right-arrow ATP·E1 + K+). In the other branch, pathway B, the slow release of K+ from E2(K+) via E2(K+) right-arrow E1·K+ right-arrow E1 + K+ is followed by high affinity ATP binding to E1. Accordingly, a mutation causing a change in K+ stimulation of Na-ATPase at micromolar ATP concentration may reflect a change in K'ATP(L) (pathway A) and/or a change in rate of the second pathway (pathway B). Fig. 4 shows that both alpha 1M32 and alpha 1M40 have significantly higher apparent affinities for low affinity ATP binding compared with alpha 1 (see K'ATP(L) values in Table I). In contrast, alpha 1M46 and alpha 1M49 have K'ATP(L) values similar to that of the wild type alpha 1 enzyme, consistent with the observed reversal of the K+ effect on Na-ATPase at 1 µM ATP. It was noted, however, that the K'ATP(L) of alpha 1M56 is lower that that of alpha 1 even though this enzyme is inhibited by K+ at low ATP. This characteristic of alpha 1M56 is considered further in the "Discussion."


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 4.   Effect of N-terminal deletions on ATP dependence of Na,K-ATPase activity. ATP hydrolysis was assayed in the presence of 100 mM NaCl, 10 mM KCl, 3 mM MgSO4, and varying ATP concentrations as described under "Experimental Procedures," and normalized to 100% VMAX. Results are taken from a representative experiment; shown are the average ± S.D. of triplicate determinations. Symbols are as in the legend to Fig. 2.

(ii) Analysis of Partial Reactions Relevant to Conformational Transitions-- In another series of experiments we compared the slow release of K+ from E2(K+) via the branch E2(K+) right-arrow E1·K+ right-arrow E1 + K+ for each of the mutants. As in our earlier studies (25, 27) we used an indirect approach whereby the relatively slow rate of E1 formation from E2(K+) is estimated at various periods following dilution of preformed E2(K+) in Na+ medium containing [gamma -32P]ATP at 10 °C. Assuming that the ensuing phosphorylation of E1 is rapid, the amount of phosphoenzyme (presumably Na·E1P since oligomycin is present to trap this intermediate) is thus a measure of E1 formed from E2(K+). As shown in Fig. 5, the changes in E2(K+) deduced from the increases in E1P, fit well to single exponentials. The rate constants for alpha 1M32 and alpha 1M40 shown in Table II are significantly higher than that of alpha 1. (Rate constants are similar to our previously published values for alpha 1 and alpha 1M32, Ref. 25). This result suggests that for both alpha 1M32 and alpha 1M40 the E2(K+) left-right-arrow left-right-arrow E1 + K+ poise is shifted to the right. On the other hand, values for alpha 1M46, alpha 1M49, and alpha 1M56 are similar to, or even lower than, those for alpha 1M32 and alpha 1M40, suggesting that deletion of >= 46 residues reverses the above right-shift to a more wild type-like E1/E2 distribution. It should be noted, however, that whereas the K+ sensitivity of Na-ATPase at 1 µM ATP reflects overall turnover via both branch pathways of K+ deocclusion, with the contribution of pathway A increasing as K'ATP(L) decreases, the time course of formation of E1 from E2(K+) reflects only deocclusion via pathway B. It is not known whether changes in each of the two pathways are quantitatively equivalent. They may not be equivalent. Thus, K+ stimulation of the Na-ATPase is notably greater for alpha 1M40 compared with alpha 1M32 despite their similar rates of E2(K+) right-arrow E1; K+ inhibition profiles of alpha 1M46 and alpha 1M49 are similar to that of alpha 1, yet their rates of E2(K+) right-arrow E1 are slower than that of alpha 1. Despite these issues and the fact that this reaction was analyzed at 10 °C, the generally consistent pattern of increasing followed by decreasing rates of E2(K+) right-arrow E1 associated with progressive deletions, is noteworthy.


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 5.   Rate of formation of E1 from E2(K+). The rate of K+ deocclusion was measured indirectly as the rate of formation of E1 from E2(K+) at 10 °C as described under "Experimental Procedures." Results shown are taken from a representative experiment; each value is the mean ± S.D. of triplicate determinations. Symbols are as in the legend to Fig. 2.

                              
View this table:
[in this window]
[in a new window]
 
Table II
Summary of conformational transition rates of Na,K-ATPase mutants

To investigate the contribution of the conformational transition of the phosphoenzyme to the E1 left-right-arrow E2 shifts observed above, we examined the E1P right-arrow E2P transition at 0 °C as previously described (28, 29). Accordingly, the enzyme is first phosphorylated by [gamma -32P]ATP at high salt concentration (600 mM NaCl) to stabilize E1P. Dephosphorylation is then initiated by a downward jump in NaCl concentration to 100 mM with the simultaneous addition of 20 mM KCl and 10 µM unlabeled ATP. Since the rate of K+-activated dephosphorylation of E2P is much faster than that of the preceding formation of E2P from E1P, the time course of the E1P decay reflects primarily E1P right-arrow E2P. As shown in Fig. 6 and summarized in Table II, compared with the wild type alpha 1 enzyme, the rate of this transition is ~6-fold slower for alpha 1M32 and alpha 1M40. Mutants alpha 1M46, alpha 1M49, and alpha 1M56 have similar or only slightly slower dephosphorylation rates relative to the wild type enzyme. Taken together, these partial reaction analyses of the mutants and wild type enzyme reflect the behavior seen in assays of the overall catalytic cycle summarized in Table I.


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 6.   Rate of formation of E2P from E1P. The rate of E1P right-arrow E2P was measured indirectly at 0 °C as described under "Experimental Procedures." The results are taken from a representative experiment with mean ± S.D. of triplicate determinations. Symbols are as in the legend to Fig. 2.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The primary sequences of the N and C termini are the least conserved domains among the various P-type ATPases found in lower organisms and throughout the plant and animal kingdom. These extramembranous termini contain regions that inhibit pump activity, as well as binding motifs for regulatory proteins that may release pump inhibition by these auto-inhibitory sequences (34). Examples include the plasma membrane Ca2+-ATPase, which contains auto-inhibitory domains in its N terminus in plants or in its C terminus in animals (35-37). Despite their low homology, a structural paradigm does exist for the N terminus of P-type ATPases, whereby the region comprises two domains. These are: (i) a variable domain, which differs markedly in sequence and length among the ATPases and (ii) a homologous domain that continues into the S1 stalk region of the N terminus (38). The variable domain, as the name indicates, varies greatly in size from the very long termini of metal-transporting ATPases such as the Cu-ATPase (39, 40) to being virtually absent in the sarcoplasmic reticulum Ca2+-ATPase (SERCA).1 The homologous domain consists of about 33 amino acids and has a high propensity to form two short helices in H,K-ATPase, SERCA, and Na,K-ATPase (38), which, in the latter pump, comprises helices H2 and H3 described below.

The N terminus of the Na,K-ATPase is a highly charged and flexible structure, with a high degree of helicity (see Fig. 1). Although the primary sequence of this region diverges greatly among isoforms and species, the following features persist: (i) a lysine-rich cluster of about 5-9 residues and (ii) a highly conserved 10 amino acid sequence circumscribed by two methionines (M(D/E)ELKKE(I/V)(S/T)M) (41) and containing a proteolytically sensitive lysine residue (5).

In his landmark studies, Jorgensen showed that the lysine-rich domain of the N terminus of the Na,K-ATPase precedes a proteolytically sensitive site (T2) that can be selectively cleaved by trypsin when the enzyme is in the E1 conformation (5, 6). Cleavage at this residue increases K'K and decreases K'ATP, with associated effects on the phosphorylation and dephosphorylation reactions of the enzyme (42-44), providing evidence for a shift in the E1/E2 equilibrium toward E1 forms (45, 46). Several studies have demonstrated that although the lysine cluster is not essential to pump function (47-51), the N terminus may play a role in Na+ sensitivity (52), K+ affinity, and in the dependence on membrane potential (53, 54) likely resulting from changes in rates of Na+ translocation (41) and K+ deocclusion reactions (55).

We have previously shown that deletion of up to 27 residues preceding the first putative helix has no effect on the conformational equilibrium of the enzyme (7, 8, 25). Only upon deletion of 32 residues, which corresponds to T2 described above, is there a shift toward E1 (8, 25). Here we show that disruption (alpha 1M32) or loss (alpha 1M40) of H1 results in a progressive shift toward E1 forms of the enzyme. We also show that disruption (alpha 1M46 and alpha 1M49) or loss (alpha 1M56) of H2 (as well as H1) reverses the shift to a more wild type-like E1 left-right-arrow E2 equilibrium.

The aforementioned progressive changes notwithstanding, the behavior of alpha 1M56 is slightly peculiar. Unlike alpha 1M46 and alpha 1M49, alpha 1M56 retained a lower K'ATP(L) even though all three mutants resemble wild type alpha 1 with respect to the following: (i) vanadate sensitivity, (ii) sensitivity to K+ inhibition at low ATP, (iii) rate of E1 formation from E2(K+), and (iv) rate of E1P right-arrow E2P. These observations may indicate some change or destabilization of structure that occurs with extensive truncation. For example, truncation beyond the first 49 residues may perturb a heretofore undefined interaction of the N terminus with another region, which may cause ligand-specific effects independent of the conformational transitions, such as an increased access of nucleotide substrate to the binding site.

Cytoplasmic Interactions Involved in Conformational Transitions-- Insights into cytoplasmic region(s) that interact with the N terminus were first obtained by Jorgensen and Collins (56) who proposed salt-bridge formation between the N terminus and other cytoplasmic domains. In a later study (8), the remarkable synergistic effects of the Delta 32 deletion and the E233K mutation implicated the N terminus/M2-M3 loop in such a salt-bridge formation. It is noteworthy that the cytoplasmic region encompassing the N terminus/M2-M3 loop is analogous to the Activator or A domain identified in the crystal structure of SERCA1a (57). In the Na,K-ATPase, interaction of the A domain with the catalytic loop was observed in the studies of Karlish and co-workers who used metal catalyzed cleavage to study domain interactions of the Na,K-ATPase in E1 versus E2 conformations (for review, see Ref. 58). Accordingly, in the E1 conformation, the nucleotide binding domain in the catalytic M4-M5 loop docks onto the phosphorylation domain in M4-M5, and domain A moves aside. In E2(K+), domain A docks onto the phosphorylation domain, and the nucleotide binding domain is displaced. It is noteworthy that all of the data are consistent with the published SERCA1a crystal structure and with further structural evidence that E1 left-right-arrow left-right-arrow E2P transitions of SERCA involve large domain movements (57). The emerging picture is that the structural changes underlying conformational transitions are generally similar for SERCA and the Na,K-ATPase, and much can be extrapolated about their analogous structures (for a detailed comparison, see Ref. 59). A main structural distinction is the N terminus, which is encompassed by domain A. In SERCA, the N terminus is a much shorter extension from the M1 transmembrane helix, lacking the first helical domain, and that which remains has a uniquely different primary sequence from that of the Na,K-ATPase.

The Distinct Modulatory Role of the N Terminus of the Na,K-ATPase-- The present mutagenesis study reveals a specific role of the N terminus of the Na,K-ATPase. The model shown in Fig. 7 depicts a region of the N terminus that acts as an autoregulatory domain modulating the E1/E2 conformational transitions. In the case of the wild type enzyme (Fig. 7, panel A), helical region H2 can interact with H1 either through helix-helix interactions and/or salt-bridge formation in the E2 conformation, allowing the M2-M3 loop and the catalytic loop to come together (shaded ovals). H2 can also interact with a domain of the M2-M3 loop in E1 to keep it apart from the catalytic loop as in the E1 conformation. When H1 is disrupted or lost (alpha 1M32 or alpha 1M40, see Fig. 7, panel B), H2 preferentially interacts with the M2-M3 loop, placing a constraint on the latter, thereby weakening the M2-M3/M4-M5 interaction and consequently stabilizing the E1 conformation. The result is a shift in the conformational equilibrium in favor of E1. Lastly, the disruption (alpha 1M46 and alpha 1M49) or loss of H2 (alpha 1M56) (see Fig. 7, panel C) alleviates the constraint on the M2-M3 loop allowing it once again to freely interact with the large catalytic M4-M5 loop, thus resembling the wild type alpha 1 enzyme.


View larger version (29K):
[in this window]
[in a new window]
 
Fig. 7.   Hypothetical model for N-terminal regulation of conformational equilibrium. Based on evidence from earlier work and the present study, a model is proposed whereby an autoregulatory region of the N terminus modulates the poise in E1 left-right-arrow E2. For details see "Discussion."

It is also noteworthy that the alpha 2 and alpha 3 isoforms of the catalytic subunit of the rat Na,K-ATPase have similar helical structures in their N termini. Furthermore, analogous disruptions of the first helix of alpha 2 and alpha 3 (mutants alpha 2M30 and alpha 3M26, respectively)2 shift the conformational equilibrium for each enzyme toward E1 forms, suggesting that the N terminus of the Na,K-ATPase may carry an autoregulatory domain present in all three isoforms.

In conclusion, we have identified an autoregulatory domain within the N terminus of the sodium pump, which modulates conformational transitions, suggesting novel intramolecular interactions within the cytoplasmic domains of the enzyme. Studies are currently underway to further pinpoint the residues in the N terminus that are involved in these interactions.

    ACKNOWLEDGEMENTS

We thank Zahid Z. Javaid for preparation of the alpha 1M40 and alpha 1M56 constructs and Dr. Alex Therien for helpful discussions and critical reading of the manuscript. The excellent technical assistance of Rosemarie Scanzano is gratefully acknowledged.

    FOOTNOTES

* This work was supported by operating grants from the Canadian Institutes of Health Research (Grant MT-3876) and the Quebec Heart and Stroke Foundation (to R. B.), the National Institutes of Health (Grant HL 49204) (to L. K.), and a predoctoral fellowship from the Heart and Stroke Foundation of Canada (to L. S.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed: Montreal General Hospital Research Inst., 1650 Cedar Ave., Rm. L11-132, Montreal, Quebec H3G 1A4, Canada. Tel.: 514-934-1934 (ext. 44501); Fax: 514-934-8332; E-mail: Rhoda.Blostein@mcgill.ca.

Published, JBC Papers in Press, July 10, 2002, DOI 10.1074/jbc.M206115200

2 L. Segall, S. E. Daly, and R. Blostein, unpublished observation.

    ABBREVIATIONS

The abbreviation used is: SERCA, sarcoplasmic reticulum Ca2+-ATPase.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Sweadner, K. J. (1989) Biochim. Biophys. Acta 988, 185-220[Medline] [Order article via Infotrieve]
2. Lingrel, J. B., and Kuntzweiler, T. (1994) J. Biol. Chem. 269, 19659-19662[Free Full Text]
3. Mercer, R. W., Biemesderfer, D., Bliss, D. P., Jr., Collins, J. H., and Forbush, B. 3 rd. (1993) J. Cell Biol. 121, 579-586[Abstract/Free Full Text]
4. Therien, A. G., and Blostein, R. (2000) Am. J. Physiol. 279, C541-66
5. Jorgensen, P. L. (1975) Biochim. Biophys. Acta 401, 399-415[Medline] [Order article via Infotrieve]
6. Jorgensen, P. L. (1977) Biochim. Biophys. Acta 466, 97-108[Medline] [Order article via Infotrieve]
7. Daly, S. E., Lane, L. K., and Blostein, R. (1994) J. Biol. Chem. 269, 23944-23948[Abstract/Free Full Text]
8. Boxenbaum, N., Daly, S. E., Javaid, Z. Z., Lane, L. K., and Blostein, R. (1998) J. Biol. Chem. 273, 23086-23092[Abstract/Free Full Text]
9. Frishman, D., and Argos, P. (1996) Prot. Engin. 9, 133-142[Abstract/Free Full Text]
10. Baldi, P., Brunak, S., Frasconi, P., Soda, G., and Pollastri, G. (1999) Bioinformatics 15, 937-946[Abstract/Free Full Text]
11. Geourjon, C., and Deleage, G. (1995) Comp. Appl. Biosci. 11, 681-684[Abstract/Free Full Text]
12. Garnier, J., Gibrat, J. F., and Robson, B. (1996) Methods Enzymol. 266, 540-553[Medline] [Order article via Infotrieve]
13. Deleage, G., and Roux, B. (1987) Prot. Engin. 1, 289-294[Abstract/Free Full Text]
14. Levitt, M. (1978) Biochemistry 17, 4277-4285[CrossRef][Medline] [Order article via Infotrieve]
15. Chou, P. Y., and Fasman, G. D. (1978) Adv. Enzymol. Rel. Areas Mol. Biol. 47, 45-148[Medline] [Order article via Infotrieve]
16. Lupas, A., Van Dyke, M., and Stock, J. (1991) Science 252, 1162-1164[CrossRef][Medline] [Order article via Infotrieve]
17. Stultz, R., Nambudripad, R., Lathrop, R. H., and White, J. V. (1997) in Protein Structural Biology in Bio-Medical Research (Allewell, N. , and Woodward, C., eds), Vol. 22B , pp. 447-506, JAI Press, Greenwich
18. Chen, C., and Okayama, H. (1987) Mol. Cell. Biol. 7, 2745-2752[Abstract/Free Full Text]
19. Jewell, E. A., and Lingrel, J. B. (1991) J. Biol. Chem. 266, 16925-16930[Abstract/Free Full Text]
20. Lane, L. K., Feldmann, J. M., Flarsheim, C. E., and Rybczynski, C. L. (1993) J. Biol. Chem 268, 17930-17934[Abstract/Free Full Text]
21. Arguello, J. M., and Lingrel, J. B. (1995) J. Biol. Chem. 270, 22764-22771[Abstract/Free Full Text]
22. Markwell, M. A., Haas, S. M., Tolbert, N. E., and Bieber, L. L. (1981) Methods Enzymol. 72, 296-303[Medline] [Order article via Infotrieve]
23. Blostein, R. (1988) Methods Enzymol. 156, 171-178[Medline] [Order article via Infotrieve]
24. Munzer, J. S., Daly, S. E., Jewell-Motz, E. A., Lingrel, J. B., and Blostein, R. (1994) J. Biol. Chem. 269, 16668-16676[Abstract/Free Full Text]
25. Daly, S. E., Lane, L. K., and Blostein, R. (1996) J. Biol. Chem. 271, 23683-23689[Abstract/Free Full Text]
26. DeLean, A., Munson, P. J., and Rodbard, D. (1978) Am. J. Physiol. 235, E97-102[Abstract/Free Full Text]
27. Therien, A. G., and Blostein, R. (1999) Am. J. Physiol. 277, C891-8[Abstract/Free Full Text]
28. Klodos, I., Post, R. L., and Forbush, B., 3rd. (1994) J. Biol. Chem. 269, 1734-1743[Abstract/Free Full Text]
29. Vilsen, B. (1997) Biochemistry 36, 13312-13324[CrossRef][Medline] [Order article via Infotrieve]
30. Cantley, L. C., Jr., Cantley, L. G., and Josephson, L. (1978) J. Biol. Chem. 253, 7361-7368[Free Full Text]
31. Post, R. L., Hegyvary, C., and Kume, S. (1972) J. Biol. Chem. 247, 6530-6540[Abstract/Free Full Text]
32. Esmann, M., and Skou, J. C. (1985) Biochem. Biophys. Res. Commun. 127, 857-863[CrossRef][Medline] [Order article via Infotrieve]
33. Sachs, J. R. (1994) Biochim. Biophys. Acta 1193, 199-211[Medline] [Order article via Infotrieve]
34. Palmgren, M. G., and Axelsen, K. B. (1998) Biochim. Biophys. Acta 1365, 37-45[Medline] [Order article via Infotrieve]
35. Harper, J. F., Hong, B., Hwang, I., Guo, H. Q., Stoddard, R., Huang, J. F., Palmgren, M. G., and Sze, H. (1998) J. Biol. Chem. 273, 1099-1106[Abstract/Free Full Text]
36. Malmstrom, S., Askerlund, P., and Palmgren, M. G. (1997) FEBS Lett. 400, 324-328[CrossRef][Medline] [Order article via Infotrieve]
37. Penniston, J. T., and Enyedi, A. (1998) J. Membr. Biol. 165, 101-109[CrossRef][Medline] [Order article via Infotrieve]
38. Moller, J. V., Juul, B., and le Maire, M. (1996) Biochim. Biophys. Acta 1286, 1-51[Medline] [Order article via Infotrieve]
39. Vulpe, C., Levinson, B., Whitney, S., Packman, S., and Gitschier, J. (1993) Nat. Genet 3, 7-13[CrossRef][Medline] [Order article via Infotrieve]
40. Bull, P. C., Thomas, G. R., Rommens, J. M., Forbes, J. R., and Cox, D. W. (1993) Nat. Genet. 5, 327-337[CrossRef][Medline] [Order article via Infotrieve]
41. Wang, X., Jaisser, F., and Horisberger, J. D. (1996) J. Physiol. 491, 579-594[Medline] [Order article via Infotrieve]
42. Jorgensen, P. L., and Klodos, I. (1978) Biochim. Biophys. Acta 507, 8-16[Medline] [Order article via Infotrieve]
43. Jorgensen, P. L., Skriver, E., Hebert, H., and Maunsbach, A. B. (1982) Ann. N. Y. Acad. Sci. 402, 207-225[CrossRef][Medline] [Order article via Infotrieve]
44. Jorgensen, P. L., and Petersen, J. (1985) Biochim. Biophys. Acta 821, 319-333[Medline] [Order article via Infotrieve]
45. Jorgensen, P. L., and Karlish, S. J. (1980) Biochim. Biophys. Acta 597, 305-317[Medline] [Order article via Infotrieve]
46. Jorgensen, P. L., and Andersen, J. P. (1988) J. Membr. Biology 103, 95-120[CrossRef][Medline] [Order article via Infotrieve]
47. Shanbaky, N. M., and Pressley, T. A. (1994) Am. J. Physiol. 267, C590-597[Abstract/Free Full Text]
48. Ohta, T., Noguchi, S., Nakanishi, M., Mutoh, Y., Hirata, H., Kagawa, Y., and Kawamura, M. (1991) Biochim. Biophys. Acta 1059, 157-164[Medline] [Order article via Infotrieve]
49. Burgener-Kairuz, P., Horisberger, J. D., Geering, K., and Rossier, B. C. (1991) FEBS Lett. 290, 83-86[CrossRef][Medline] [Order article via Infotrieve]
50. Mutoh, Y., Noguchi, S., Ohta, T., Higashi, K., Takasugi, M., Kuroiwa, A., and Kawamura, M. (1992) Biochem. Intl. 26, 775-785[Medline] [Order article via Infotrieve]
51. Baxter-Lowe, L. A., Guo, J. Z., Bergstrom, E. E., and Hokin, L. E. (1989) FEBS Lett. 257, 181-187[CrossRef][Medline] [Order article via Infotrieve]
52. Ishii, T., Lemas, M. V., and Takeyasu, K. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 6103-6107[Abstract/Free Full Text]
53. Vasilets, L. A., Omay, H. S., Ohta, T., Noguchi, S., Kawamura, M., and Schwarz, W. (1991) J. Biol. Chem. 266, 16285-16288[Abstract/Free Full Text]
54. Vasilets, L. A., Ohta, T., Noguchi, S., Kawamura, M., and Schwarz, W. (1993) Eur. Biophys. J. 21, 433-443[Medline] [Order article via Infotrieve]
55. Wierzbicki, W., and Blostein, R. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 70-74[Abstract/Free Full Text]
56. Jorgensen, P. L., and Collins, J. H. (1986) Biochim. Biophys. Acta 860, 570-576[Medline] [Order article via Infotrieve]
57. Toyoshima, C., Nakasako, M., Nomura, H., and Ogawa, H. (2000) Nature 405, 647-655[CrossRef][Medline] [Order article via Infotrieve]
58. Goldshleger, R., Patchornik, G., Shimon, M. B., Tal, D. M., Post, R. L., and Karlish, S. J. (2001) J. Bioenerg. Biomembr. 33, 387-399[CrossRef][Medline] [Order article via Infotrieve]
59. Sweadner, K. J., and Donnet, C. (2001) Biochem. J. 356, 685-704[CrossRef][Medline] [Order article via Infotrieve]
60. Shull, G. E., Greeb, J., and Lingrel, J. B. (1986) Biochemistry 25, 8125-8132[CrossRef][Medline] [Order article via Infotrieve]


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page